Welcome to LookChem.com Sign In|Join Free
  • or
1,3,5-Triazin-2-amine, 4-chloro-N-methyl-6-(4-morpholinyl)-N-phenyl- is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

189078-47-5

Post Buying Request

189078-47-5 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

189078-47-5 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 189078-47-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,8,9,0,7 and 8 respectively; the second part has 2 digits, 4 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 189078-47:
(8*1)+(7*8)+(6*9)+(5*0)+(4*7)+(3*8)+(2*4)+(1*7)=185
185 % 10 = 5
So 189078-47-5 is a valid CAS Registry Number.

189078-47-5Downstream Products

189078-47-5Relevant academic research and scientific papers

Synthesis and aromatase-inhibitory activity of imidazolyl-1,3,5-triazine derivatives

Matsuno, Toshiyuki,Kato, Masanobu,Tsuchida, Yoshio,Takahashi, Masayuki,Yaguchi, Sin-Ichi,Terada, Sumio

, p. 291 - 296 (1997)

Triamino-substituted 1,3,5-triazine derivatives were synthesized and tested for inhibitory activities against the aromatase of human placental microsomes and the cytochrome P450 side chain cleavage of cholesterol (P450(SCC)) of pig adrenal mitochondria. The compounds having imidazolyl and tertiary amino groups as substituents in the 1,3,5-triazine ring showed significant aromatase-inhibitory activity. Among them, compounds 17, 23, 26, 27 and 28 were more active than the reference compound, CGS 16949A. The inhibitory activities of these compounds against P450(SCC) were much weaker than their aromatase-inhibitory activities. These compounds may be regarded as selective aromatase inhibitors.

NOVEL 1,3,5 -TRIAZINE BASED PI3K INHIBITORS AS ANTICANCER AGENTS AND A PROCESS FOR THE PREPARATION THEREOF

-

Paragraph 026, (2016/06/15)

The present invention describes heterocyclic compounds of general Formula 1 and their method of preparation thereof. The present invention describes general Formula 1 which inhibits phosphoinositide 3-kinase (PI3K) and can be used as the anticancer agents

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 189078-47-5